{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:44Z","timestamp":1762505384792},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T00:00:00Z","timestamp":1221782400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Two high-risk genes have been implicated in the development of CM (cutaneous melanoma). Germline mutations of the CDKN2A gene are found in &lt; 25% of melanoma-prone families and there are only seven families with mutation of the<jats:italic>CDK4<\/jats:italic>gene reported to date. Beside those high penetrance genes, certain allelic variants of the<jats:italic>MC1R<\/jats:italic>gene modify the risk of developing the disease.<\/jats:p><jats:p>The aims of our study were: to determine the prevalence of germline<jats:italic>CDKN2A<\/jats:italic>mutations and variants in members of families with familial CM and in patients with multiple primary CM; to search for possible<jats:italic>CDK4<\/jats:italic>mutations, and to determine the frequency of variations in the<jats:italic>MC1R<\/jats:italic>gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From January 2001 until January 2007, 64 individuals were included in the study. The group included 28 patients and 7 healthy relatives belonging to 25 families, 26 patients with multiple primary tumors and 3 children with CM. Additionally 54 healthy individuals were included as a control group. Mutations and variants of the melanoma susceptibility genes were identified by direct sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Seven families with CDKN2A mutations were discovered (7\/25 or 28.0%). The L94Q mutation found in one family had not been previously reported in other populations. The D84N variant, with possible biological impact, was discovered in the case of patient without family history but with multiple primary CM. Only one mutation carrier was found in the control group. Further analysis revealed that c.540C&gt;T heterozygous carriers were more common in the group of CM patients and their healthy relatives (11\/64 vs. 2\/54). One p14ARF variant was discovered in the control group and no mutations of the<jats:italic>CDK4<\/jats:italic>gene were found.<\/jats:p><jats:p>Most frequently found variants of the<jats:italic>MC1R<\/jats:italic>gene were T314T, V60L, V92M, R151C, R160W and R163Q with frequencies slightly higher in the group of patients and their relatives than in the group of controls, but the difference was statistically insignificant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The present study has shown high prevalence of p16INK4A mutations in Slovenian population of familial melanoma patients (37%) and an absence of p14ARF or<jats:italic>CDK4<\/jats:italic>mutations.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1471-2350-9-86","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T18:13:41Z","timestamp":1221848021000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevalence of variations in melanoma susceptibility genes among Slovenian melanoma families"],"prefix":"10.1186","volume":"9","author":[{"given":"Barbara","family":"Peric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Cerkovnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srdjan","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janez","family":"Zgajnar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Besic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marko","family":"Hocevar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,9,19]]},"reference":[{"issue":"3","key":"380_CR1","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/sj.jid.5700094","volume":"126","author":"MJ Eliason","year":"2006","unstructured":"Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA: Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol. 2006, 126 (3): 660-6. 10.1038\/sj.jid.5700094.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"380_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10227-001-0037-6","volume":"6","author":"P Gibbs","year":"2002","unstructured":"Gibbs P, Brady BM, Robinson WA: The genes and genetics of malignant melanoma. J Cutan Med Surg. 2002, 6 (3): 229-35.","journal-title":"J Cutan Med Surg"},{"issue":"20","key":"380_CR3","doi-asserted-by":"publisher","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","volume":"66","author":"AM Goldstein","year":"2006","unstructured":"Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de PB, Bruno W, Calista D, et al: High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res. 2006, 66 (20): 9818-28. 10.1158\/0008-5472.CAN-06-0494.","journal-title":"Cancer Res"},{"issue":"8","key":"380_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nrc1145","volume":"3","author":"L Chin","year":"2003","unstructured":"Chin L: The genetics of malignant melanoma: lessons from mouse and man. Nat Rev Cancer. 2003, 3 (8): 559-70. 10.1038\/nrc1145.","journal-title":"Nat Rev Cancer"},{"key":"380_CR5","doi-asserted-by":"crossref","unstructured":"Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA: Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst. 92 (12): 1006-10. 10.1093\/jnci\/92.12.1006. 2000 Jun 21","DOI":"10.1093\/jnci\/92.12.1006"},{"issue":"15","key":"380_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199510123331504","volume":"333","author":"AM Goldstein","year":"1995","unstructured":"Goldstein AM, Fraser MC, Struewing JP, Hussussian CJ, Ranade K, Zametkin DP, Fontaine LS, Organic SM, Dracopoli NC, Clark WH: Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med. 1995, 333 (15): 970-4. 10.1056\/NEJM199510123331504.","journal-title":"N Engl J Med"},{"issue":"3","key":"380_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1097\/CMR.0b013e328014a2cd","volume":"17","author":"D Pjanova","year":"2007","unstructured":"Pjanova D, Engele L, Randerson-Moor JA, Harland M, Bishop DT, Newton Bishop JA, Taylor C, Debniak T, Lubinski J, Kleina R, Heisele O: CDKN2A and CDK4 variants in Latvian melanoma patients: analysis of a clinic-based population. Melanoma Res. 2007, 17 (3): 185-91. 10.1097\/CMR.0b013e328014a2cd.","journal-title":"Melanoma Res"},{"issue":"11","key":"380_CR8","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1002\/ijc.22210","volume":"119","author":"T Debniak","year":"2006","unstructured":"Debniak T, Scott R, Masojc B, Serrano-Fernandez P, Huzarski T, Byrski T, Debniak B, Gorski B, Cybulski C, Medrek K, Kurzawski G, van de WT, et al: MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer. 2006, 119 (11): 2597-602. 10.1002\/ijc.22210.","journal-title":"Int J Cancer"},{"issue":"2","key":"380_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00001622-200303000-00007","volume":"15","author":"RF Kefford","year":"2003","unstructured":"Kefford RF, Mann GJ: Is there a role for genetic testing in patients with melanoma?. Curr Opin Oncol. 2003, 15 (2): 157-61. 10.1097\/00001622-200303000-00007.","journal-title":"Curr Opin Oncol"},{"issue":"2","key":"380_CR10","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1046\/j.0022-202x.2001.01421.x","volume":"117","author":"C Kennedy","year":"2001","unstructured":"Kennedy C, ter HJ, Berkhout M, Gruis N, Bastiaens M, Bergman W, Willemze R, Bavinck JN: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol. 2001, 117 (2): 294-300. 10.1046\/j.0022-202x.2001.01421.x.","journal-title":"J Invest Dermatol"},{"key":"380_CR11","unstructured":"Cancer Incidence in Slovenia 2004. 2007, Ljubljana. Institute of Oncology, Cancer Registry of Slovenia"},{"issue":"6","key":"380_CR12","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/00008390-200312000-00005","volume":"13","author":"M Avbelj","year":"2003","unstructured":"Avbelj M, Hocevar M, Trebusak-Podkrajsek K, Krzisnik C, Battelino T: A novel L94Q mutation in the CDKN2A gene in a melanoma kindred. Melanoma Res. 2003, 13 (6): 567-70. 10.1097\/00008390-200312000-00005.","journal-title":"Melanoma Res"},{"issue":"5","key":"380_CR13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1158\/1055-9965.808.13.5","volume":"13","author":"PA Kanetsky","year":"2004","unstructured":"Kanetsky PA, Ge F, Najarian D, Swoyer J, Panossian S, Schuchter L, Holmes R, Guerry D, Rebbeck TR: Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach. Cancer Epidemiol Biomarkers Prev. 2004, 13 (5): 808-19.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"380_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ng0196-97","volume":"12","author":"L Zuo","year":"1996","unstructured":"Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N, Dracopoli NC: Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet. 1996, 12 (1): 97-9. 10.1038\/ng0196-97.","journal-title":"Nat Genet"},{"issue":"7","key":"380_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/jmg.2003.016907","volume":"41","author":"MT Landi","year":"2004","unstructured":"Landi MT, Goldstein AM, Tsang S, Munroe D, Modi W, Ter-Minassian M, Steighner R, Dean M, Metheny N, Staats B, Agatep R, Hogg D, et al: Genetic susceptibility in familial melanoma from northeastern Italy. J Med Genet. 2004, 41 (7): 557-66. 10.1136\/jmg.2003.016907.","journal-title":"J Med Genet"},{"issue":"2","key":"380_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.18388\/abp.2002_3795","volume":"49","author":"K Lamperska","year":"2002","unstructured":"Lamperska K, Karezewska A, Kwiatkowska E, Mackiewicz A: Analysis of mutations in the p16\/CDKN2A gene in sporadic and familial melanoma in the Polish population. Acta Biochim Pol. 2002, 49 (2): 369-76.","journal-title":"Acta Biochim Pol"},{"issue":"2","key":"380_CR17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jdermsci.2007.08.006","volume":"49","author":"A Lukowsky","year":"2008","unstructured":"Lukowsky A, Schafer-Hesterberg G, Sterry W, Voit C: Germline CDKN2A\/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients. J Dermatol Sci. 2008, 49 (2): 163-5. 10.1016\/j.jdermsci.2007.08.006.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"380_CR18","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1093\/jnci\/94.12.894","volume":"94","author":"DT Bishop","year":"2002","unstructured":"Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de PB, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, et al: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst. 2002, 94 (12): 894-903.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"380_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1086\/303001","volume":"67","author":"P Ciotti","year":"2000","unstructured":"Ciotti P, Struewing JP, Mantelli M, Chompret A, Avril MF, Santi PL, Tucker MA, Bianchi-Scarra G, Bressac-de PB, Goldstein AM: A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families. Am J Hum Genet. 2000, 67 (2): 311-9. 10.1086\/303001.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"380_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1025758527675","volume":"2","author":"FA de Snoo","year":"2003","unstructured":"de Snoo FA, Bergman W, Gruis NA: Familial melanoma: a complex disorder leading to controversy on DNA testing. Fam Cancer. 2003, 2 (2): 109-16. 10.1023\/A:1025758527675.","journal-title":"Fam Cancer"},{"issue":"28","key":"380_CR21","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1038\/sj.onc.1208678","volume":"24","author":"M Harland","year":"2005","unstructured":"Harland M, Taylor CF, Chambers PA, Kukalizch K, Randerson-Moor JA, Gruis NA, de Snoo FA, ter Huurne JA, Goldstein AM, Tucker MA, Bishop DT, Bishop JA: A mutation hotspot at the p14ARF splice site. Oncogene. 2005, 24 (28): 4604-8. 10.1038\/sj.onc.1208678.","journal-title":"Oncogene"},{"issue":"12","key":"380_CR22","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1038\/sj.bjc.6602629","volume":"92","author":"C Marian","year":"2005","unstructured":"Marian C, Scope A, Laud K, Friedman E, Pavlotsky F, Yakobson E, Bressac-de PB, Azizi E: Search for germline alterations in CDKN2A\/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours. Br J Cancer. 2005, 92 (12): 2278-85. 10.1038\/sj.bjc.6602629.","journal-title":"Br J Cancer"},{"issue":"1","key":"380_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejca.2007.10.006","volume":"44","author":"T Debniak","year":"2008","unstructured":"Debniak T, Scott RJ, Gorski B, Cybulski C, van de WT, Serrano-Fernandez P, Huzarski T, Byrski T, Nagay L, Debniak B, Kowalska E, Jakubowska A, et al: Common variants of DNA repair genes and malignant melanoma. Eur J Cancer. 2008, 44 (1): 110-4. 10.1016\/j.ejca.2007.10.006.","journal-title":"Eur J Cancer"},{"issue":"19","key":"380_CR24","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1093\/jnci\/89.19.1460","volume":"89","author":"DC Whiteman","year":"1997","unstructured":"Whiteman DC, Milligan A, Welch J, Green AC, Hayward NK: Germline CDKN2A mutations in childhood melanoma. J Natl Cancer Inst. 1997, 89 (19): 1460-10.1093\/jnci\/89.19.1460.","journal-title":"J Natl Cancer Inst"},{"issue":"13","key":"380_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJM199803263381305","volume":"338","author":"J Monzon","year":"1998","unstructured":"Monzon J, Liu L, Brill H, Goldstein AM, Tucker MA, From L, McLaughlin J, Hogg D, Lassam NJ: CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998, 338 (13): 879-87. 10.1056\/NEJM199803263381305.","journal-title":"N Engl J Med"},{"issue":"6","key":"380_CR26","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6","volume":"95","author":"R Kumar","year":"2001","unstructured":"Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K: A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer. 2001, 95 (6): 388-93. 10.1002\/1097-0215(20011120)95:6<388::AID-IJC1069>3.0.CO;2-6.","journal-title":"Int J Cancer"},{"issue":"1","key":"380_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.18388\/abp.2007_3277","volume":"54","author":"KM Lamperska","year":"2007","unstructured":"Lamperska KM, Przybyla A, Kycler W, Mackiewicz A: The CDKN2a common variants: 148 Ala\/Thr and 500 C\/G in 3' UTR, and their association with clinical course of melanoma. Acta Biochim Pol. 2007, 54 (1): 119-24.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"380_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/gcc.1170","volume":"32","author":"PM Pollock","year":"2001","unstructured":"Pollock PM, Stark MS, Palmer JM, Walters MK, Aitken JF, Martin NG, Hayward NK: Mutation analysis of the CDKN2A promoter in Australian melanoma families. Genes Chromosomes Cancer. 2001, 32 (1): 89-94. 10.1002\/gcc.1170.","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"380_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1590\/S0100-879X2006000200010","volume":"39","author":"J Huber","year":"2006","unstructured":"Huber J, Ramos ES: The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma. Braz J Med Biol Res. 2006, 39 (2): 237-41. 10.1590\/S0100-879X2006000200010.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"380_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/gcc.20202","volume":"44","author":"A Molven","year":"2005","unstructured":"Molven A, Grimstvedt MB, Steine SJ, Harland M, Avril MF, Hayward NK, Akslen LA: A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer. 2005, 44 (1): 10-8. 10.1002\/gcc.20202.","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"380_CR31","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/humu.20476","volume":"28","author":"MR Gerstenblith","year":"2007","unstructured":"Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT: Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat. 2007, 28 (5): 495-505. 10.1002\/humu.20476.","journal-title":"Hum Mutat"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-9-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2350-9-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-9-86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2350-9-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:54:44Z","timestamp":1684544084000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/1471-2350-9-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,19]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["380"],"URL":"https:\/\/doi.org\/10.1186\/1471-2350-9-86","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,19]]},"assertion":[{"value":"5 March 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"86"}}